<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2023</study_start_year><data_sharing_plan>IPD Sharing (as of November 2023): Yes</data_sharing_plan><condition>Metastatic Colorectal Carcinoma</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Carcinoma</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/116693</full_dataset_link><study_start_month>11</study_start_month><keyword>Pentoxifylline</keyword><keyword>Antibodies</keyword><keyword>Antibodies, Monoclonal</keyword><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer</name><description>The aim of this work is to assess the antitumor effect of Pentoxiphylline in patients with metastatic colorectal cancer receiving stomatal chemotherapy ± targeted therapy.</description><dates><creation>2023-11-15</creation></dates><accession>116693</accession><cross_references><ClinicalTrials___gov>NCT06115174</ClinicalTrials___gov></cross_references></HashMap>